Price in deferred time of 15 minutes
|
Last quote
06/02/2023 -
16:15:00
|
Bid
06/02/2023 -
15:59:59
|
Bid Volume |
Ask
06/02/2023 -
15:59:59
|
Ask Volume |
|---|---|---|---|---|
|
274.26
+6.39
(
+2.39% )
|
274.25
|
18,400 |
274.26
|
2,900 |
Analysis by TheScreener
02.06.2023
Evaluation
Interest
Sensibility
Analysis date: 02.06.2023
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 02.05.2023.
Interest
Weak
Weak
Weak interest since 26.05.2023.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 23.05.2023 at a price of 267.76.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, at its current price the stock is fairly valued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 26.05.2023), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is
4wk Rel Perf
-7.47%
-7.47%
The four week relative underperformance versus SP500 is 7.47%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 02.05.2023.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.12%.
Mkt Cap in $bn
75.45
75.45
With a market capitalization >$8bn, HCA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
1.03
1.03
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
11.77
11.77
The estimated PE is for the year 2025.
LT Growth
11.03%
11.03%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
16
16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
1.07%
1.07%
The twelve month estimated dividend yield represents 12.55% of earnings forecasts.
Beta
109
109
For 1% of index variation, the stock varies on average by 1.09%.
Correlation
0.69
0.69
68.98% of stock movements are explained by index variations.
Value at Risk
48.18
48.18
The value at risk is estimated at USD 48.18. The risk is therefore 17.57%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2011
27.07.2011